Emerging outsourcing destinations for R&D and clinical trials
Julian Remnant, Deloitte: “Western companies want to participate in the growth in healthcare in these markets. There is also a lot of scientific talent in these markets."
-
Shanghai is one of many Chinese cities welcoming foreign investment as a... -
Aparna Krishnan, IHS Global Insight: “There are disadvantages because of lax... -
Julian Remnant, Deloitte: “Western companies want to participate in the...
